How Sionna Therapeutics, Inc. stacks up

SION · against 187 other Healthcare companies of similar size

Overall

50/ 100

Above the middle of the pack.

Ranked #67 of 188 · scores higher than 64% of peers

Bars: peers in each 10-point band of the overall score

31 peers with an overall score of 50–59, including SION · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#88 of 185Score 33 / 100 · beats 39%

Growth—Not enough reported data

Profitability#130 of 193Score 18 / 100 · beats 32%Risk#2 of 206Lower relative risk · safety 99 · beats 100%

Ranking by overall score

Top 5 and the companies ranked around SION

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Q32 Bio Inc.QTTB · US-listed	261M USD	97	93	—	98	0 / 2
2	Compugen Ltd.CGEN.TA · Middle East	592M ILS (≈$160M)	84	99	99	96	1 / 2
3	Clinuvel Pharmaceuticals LimitedCUV.AX · Australia & NZ	356M AUD (≈$235M)	81	98	35	97	0 / 2
4	Clinuvel Pharmaceuticals LimitedCUVL · US-listed	256M USD	80	98	35	92	0 / 2
5	Ouro Fino Saúde Animal Participações S.A.OFSA3.SA · Brazil	1.3B BRL (≈$238M)	77	96	72	89	1 / 2
⋯
60	Upstream Bio, Inc.UPB · US-listed	186M USD	52	33	71	3	0 / 2
65	Medy-Tox Inc.086900.KQ · South Korea	406.2B KRW (≈$292M)	51	61	49	50	1 / 2
65	Organigram Global Inc.OGI · US-listed	133M USD	51	88	—	36	2 / 2
67	PT Lippo Karawaci TbkLPKR.JK · Southeast Asia	2.91T IDR (≈$180M)	50	92	6	45	1 / 2
67	Sionna Therapeutics, Inc.SION · US-listed	165M USD	50	33	—	18	0 / 2
69	Oramed Pharmaceuticals Inc.ORMP.TA · Middle East	540M ILS (≈$146M)	49	75	—	6	1 / 2
69	Panacea Biotec LimitedPANACEABIO.NS · India	20.5B INR (≈$246M)	49	7	73	34	0 / 2
71	Chong Kun Dang Holdings Corp.001630.KS · South Korea	166.9B KRW (≈$120M)	48	74	40	49	2 / 2
71	ProQR Therapeutics N.V.PRQRN.MX · Latin America	5.1B MXN (≈$274M)	48	30	85	13	1 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…